Clin2
NCT06235749Possibly a fitRecruiting

Calcium gluconate to reduce bleeding during planned C-section

Elective Cesarean Delivery

Part of Women’s health & pregnancy clinical trials.

This study tests whether giving calcium gluconate during a planned cesarean can reduce blood loss. It may be an option for women who are at least 35 weeks pregnant and have no conditions that affect calcium or heart rhythm.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,180 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are scheduled for a planned (elective) cesarean delivery.
  • Your pregnancy is at least 35 weeks (35 weeks or more).
  • You are 18 years old or older.
  • You are not taking a calcium channel blocker (like nifedipine, verapamil, or diltiazem).
  • You do not have chronic kidney failure, high phosphate levels, or sarcoidosis.
  • Your calcium levels are normal before surgery, and you have no known heart rhythm problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07714902Recruiting
Calcium gluconate to reduce bleeding during vaginal birth

This study tests if giving calcium gluconate during childbirth can reduce blood loss. It might help women having a vaginal delivery after 37 weeks of pregnancy.

Haifa
NCT07217899Recruiting· Phase 2
Calcium to reduce bleeding after C-section

This trial tests if giving calcium through an IV before a C-section can help reduce blood loss in women at higher risk for heavy bleeding due to the uterus not contracting well.

Ann Arbor, Michigan
NCT07550413Not yet recruiting· Phase 2
Calcium to reduce blood loss during cesarean section

This study tests whether giving calcium through an IV during a C-section can reduce blood loss during the procedure. It is for women who are having a C-section after labor has started and who have already received oxytocin to help with contractions.

Rawalpindi, Punjab Province
NCT07078942Not yet recruiting· Phase 4
Tranexamic acid to reduce bleeding during cesarean section

This study tests whether giving tranexamic acid, a medicine that helps blood clot, before a cesarean section can reduce blood loss during and after the surgery. It may help women who are at higher risk of bleeding during delivery.

Bangkok, Bangkok
NCT07362992Recruiting· Early Phase 1
Tranexamic acid gel to reduce bleeding during cesarean

This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.

Holon, Central District
NCT04304625Recruiting· Phase 3
Tranexamic acid to reduce blood loss after C-section

This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.

Bordeaux

Hear when a new Elective Cesarean Delivery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.